XTX Topco Ltd

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 1828301 LONDON, X0

Position in VNDA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$203,618

+$53,315 QoQ

Shares Held

33,271

+10.5% QoQ

Ownership

0.055%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#81

of 172 holders

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $413,155,276 across 381 Biotechnology names. VNDA ranks #233 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	30,522	$19,031,687
2	ASND	Ascendis Pharma A/S	43,289	$11,546,042
3	BBIO	BridgeBio Pharma, Inc.	116,611	$8,685,187
4	MRNA	Moderna, Inc.	123,281	$8,633,368
5	JAZZ	Jazz Pharmaceuticals plc	30,496	$7,348,621
6	KYMR	Kymera Therapeutics, Inc.	61,501	$7,052,319
7	CYTK	Cytokinetics Inc	80,743	$6,878,496
8	PTCT	Ptc Therapeutics, Inc.	81,923	$6,682,459

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$203,618	33,271	+10.5%	Shares	Defined	2026-08-14
2025-09-30	$150,303	30,121	-4.5%	Shares	Defined	2025-11-14
2025-06-30	$148,793	31,524	-54.5%	Shares	Defined	2025-08-12
2025-03-31	$318,220	69,329	+378.3%	Shares	Defined	2025-05-08
2024-12-31	$69,435	14,496	+9.2%	Shares	Defined	2025-02-13
2024-06-30	$75,020	13,278	-64.0%	Shares	Defined	2024-08-12
2023-12-31	$155,819	36,924	-40.9%	Shares	Defined	2024-02-13
2023-09-30	$270,060	62,514	+146.1%	Shares	Defined	2023-11-13
2023-06-30	$167,418	25,405	-2.2%	Shares	Defined	2023-08-14
2023-03-31	$176,390	25,978	-44.4%	Shares	Defined	2023-05-12
2022-12-31	$345,127	46,702	—	Shares	Defined	2023-02-14
2021-06-30 ALXN	—	3,360	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.